Form D · Biotechnology
CELLUMEN, INC.
Pittsburgh, PA · CIK 0001294231
Offering snapshot reported Mar 3, 2010 · SEC filing
- Reported sold
- $248K Offering amount: $500K
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $2K Reported outside-investor minimum
- First sale
- Mar 3, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 3, 2010 | Initial | $248,453 | No comparison | 13 | SEC filing |
| Nov 10, 2009 | Amendment | $694,272 | $0vs Oct 7, 2009 | 7 | SEC filing |
| Oct 7, 2009 | Initial | $694,272 | No comparison | 7 | SEC filing |
| May 29, 2009 | Initial | $621,758 | No comparison | Not reported | SEC filing |
| Feb 25, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 13, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 28, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 30, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Mar 13, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 17, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| May 24, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 4, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-66503
Source: Form D, filed Mar 3, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James Datin | Director |
| Gregory Finerty | Executive |
| Albert Gough | Executive |
| Patricia A. Johnston | Executive |
| Matthew Malenfant | Director |
| Rosemary Mazanet | Director |
| Le Roy L. Metz | Director |
| Dean Miller | Director |
| Franklyn Prendergast | Director |
| Jack Reynolds | Director |
| Donald P. Taylor | Executive |
| D. Lansing Taylor | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3180 William Pitt Way
Pittsburgh, PA, 15238
Pittsburgh, PA, 15238